Skip to main content
SpringerLink
Log in

Endometriumkarzinom

  • Chapter
Die Onkologie

  • 339 Accesses

Zusammenfassung

Das Endometriumkarzinom stellt die fünfthäufigste (nach dem Mamma-, Darm-, Bronchial- und Ovarialkarzinom) Krebserkrankung der Frau dar. In den alten Bundesländern belief sich die Neuerkrankungsrate im Jahre 1990 auf ca. 7800 Fälle, was einer Inzidenz von 24,7 pro 100000 Einwohnern pro Jahr entspricht. Die standardisierte Inzidenz lag in Europa bei 19,2 und weltweit bei 13.7. Im gleichen Zeitraum lag die Inzidenz des Zervixkarzinoms bei ca. 16,2% (Becker et al. 1991). Damit hat sich das Häufigkeitsverhältnis der beiden Karzinome in den letzten Jahrzehnten umgekehrt. Ursächlich hierfür wurde die Östrogensubstitution während des Klimakteriums angeführt, jedoch zeigte sich ein vergleichbarer Trend in Norwegen oder der Tschechoslowakei, wo eine Substitution unüblich war (Persson 1985). Somit dürfte in erster Linie die gestiegene Lebenserwartung für die beobachteten Entwicklungen verantwortlich sein.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Aalders JG, Abeler V, Kolstad P, Onsrud U (1980) Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma. Clinical and histopathologic study of 940 patients.Obstet Gynecol 56: 419–427

    CAS  Google Scholar 

  • Aalders JG, Abeler V, Kolstad P (1984) Stage IV endometrial carcinoma: a clinical and histopathological study of 83 patients.Gynecol Oncol 17: 75–84

    CAS  Google Scholar 

  • Abeler VM, Kjörstad KE (1990) Serous papillary carcinoma of the endometrium: A histopathological study of 22 cases. Gynecol Oncol 39: 226–271

    Google Scholar 

  • Aclerman I, Malone S, Thomas G, Franssen E, Balogh J, Dembo A (1996) Endometrial carcinoma - relative effectiveness of adjuvant irradiation vs. therapy reserved for relapse. Gynecol Oncol 60: 177–183

    Google Scholar 

  • Akkerman I, Malone S, Thomas G, Franssen E, Balogh J, Dembo A (1996) Endometrial carcinoma - relative effectiveness of adjuvant irradiation vs. therapy reserved for relapse. Gynecol Oncol 60: 177–183

    Google Scholar 

  • Assikis VJ, Bilimoria MM, Muenzner HD, Lurain JR, Jordan VC (1996) Mutations of the estrogen receptor in endometrial carcinoma:evidence of an association with high tumor grade. Gynecol Oncol 63: 192–199

    PubMed  CAS  Google Scholar 

  • Atad J, Weill S, Ben-David Y, Hallak M, Klein O, Lurie M, Abramovici H (1994) Intraoperative frozen section examination of myometrial invasion depth in patients with endometrial carcinoma. In J Gynecol Cancer 4: 352–355

    Google Scholar 

  • Baker D (1990) Estrogen replacement therapy in patients with previous endometrial carcinoma. CompTher 16: 28–35

    CAS  Google Scholar 

  • Ball HG (1996) Do we know the best therapy for early endometrial cancer? Gynecol Oncol 54: 98–306

    Google Scholar 

  • Ball HG, Blessing JA, Lentz SS, Mutch DG (1996) A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium:a Gynecologic Oncology Group study.Gynecol Oncol 62: 278–81

    PubMed  CAS  Google Scholar 

  • Barakat RR, Park RC, Grigsby PW, Muss HD, Norris HJ (1997) Corpus: Epithelial tumors. In: Hoskins WJ, Perez CA, Young RC (eds) Principles and Practise of Gynecologic Oncology, 2nd edn. Lippincott-Raven, Philadelphia, p 884

    Google Scholar 

  • Becker N, Frentzel-Beyme R, Wagner G (1991) Atlas of cancer mortality in the Federal Republic of Germany 1945–1990, 3rd edn. Springer, Berlin Heidelberg New York Tokyo; Update unter www.dkfz-heidelberg.de

    Google Scholar 

  • Behbakht K, Yordan EL, Casey C, DeGeest K, Massad LS, Kirschner CV, Wilbanks GD (1994) Prognostic indicators of survival in advanced endometrial cancer.Gynecol Oncol 55: 363–367

    CAS  Google Scholar 

  • Benedet JL, EhlenTG, Kovacs E, Ludwig H (1995) Corpus uteri carcinoma.ln: Hermanek P et al. (eds) Prognostic factors in cancer. UICC. Springer, Berlin Heidelberg New York Tokyo, pp 193–202

    Google Scholar 

  • Berchuck A, Boyd J (1995) Molecular basis of endometrial cancer. Cancer 76 [Suppl]: 2034–2040

    PubMed  CAS  Google Scholar 

  • Berchuck A (1997) Endometrial carcinoma and its precursors. Curr Ther Endocrinol Metab 6: 599–602

    PubMed  CAS  Google Scholar 

  • Berends MJ, Kleibeuker JH, de Vries EG, Mourits MJ, Hollema H, Pras E, van der Zee AG (1999) The importance of family history in young patients with endometrial cancer. Eur J Obstet Gynecol Reprod Biol 82: 139–41

    PubMed  CAS  Google Scholar 

  • Boente MP,Yordan EL, Macintosh DG, Grendys EC,Orandi YA, Davies S, Beck D,Graham JE, Miller A (1993) Prognostic factors and long-term survival in endometrial adenocarcinoma with cervical involvement. Gynecol Oncol 51: 316–322

    Google Scholar 

  • BurkeTW, Heller PB, Woodward JE, Davidson SA, Hoskins WJ, Park RC (1990) Treatment failure in endometrial carcinoma. Obstet Gynecol 75: 96–101

    Google Scholar 

  • BurkeTW, Munkarah A, Kavanagh JJ, Morris M, Levenback C,Tornos C, Gershenson DM (1993) Treatment of advanced or recurrent endometrial carcinoma with single-agent carboplatin. Gynecol Oncol 51: 397–400

    Google Scholar 

  • Calvert AH (1994) Dose optimisation of carboplatin in adults. Anticancer Res 14: 2273–2278

    PubMed  CAS  Google Scholar 

  • Carcangiu ML, Chambers JT (1992) Uterine papillary serous carcinoma: A study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma,absence of invasion, and concomitant ovarian carcinoma. Gynecol Oncol 47: 298–305

    PubMed  CAS  Google Scholar 

  • Carey MS, O’Connell GJ,Johanson CR et al. (1995) Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium. Gynecol Oncol 57: 138–144

    PubMed  CAS  Google Scholar 

  • Cecchini S, Ciatto S, Bonardi R, Mazzotta A, Grazzini G, Pacini P, Muraca MG (1996) Screening by ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen. Gynecol Oncol 60: 409–411

    PubMed  CAS  Google Scholar 

  • Childers JM, Brzechffa PR, Hatch KD, Surwit EA (1993) Laparoscopically assisted surgical staging (LASS) of endometrial cancer.Gynecol Oncol 51: 33–38

    CAS  Google Scholar 

  • Christopherson WM, Alberhasky RC, Connelly Pi (1982) Carcinoma of the endometrium. II. Papillary adenocarcinoma: a clinical pathological study of 46 cases. Am J Clin Pathol 77: 534

    PubMed  CAS  Google Scholar 

  • Coleman RL, Schinck JC, Miller DS, Bauer KD, August CZ, Rademaker AW, Lurain JR (1993) DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.Gynecol Oncol 50: 20–24

    CAS  Google Scholar 

  • Connelly PJ, Alberhasky RC, Christopherson WM (1982) Carcinoma of the endometrium. Ill. Analysis of 865 cases of adenocarcinoma and adenoacanthoma. Obstet Gynecol 59: 569–575

    PubMed  CAS  Google Scholar 

  • Corscaden JA, Gusberg SB (1947) The background of cancer of the corpus. Am J Obstet Gynec 53: 419

    PubMed  CAS  Google Scholar 

  • Cosa NZ-UK Endometrial Cancer Study Groups (1996) Pelvic lymphadenectomy in high risk endometrial cancer. Int J Gynecol Cancer 6: 102–107

    Google Scholar 

  • Covens A, Thomas G, Shaw P, Ackerman I, Osborne R, Lukka H, Carey M, Franssen E, Roche K (1997) A phase Il study of leuprolide in advanced/ recurrent endometrial cancer. Gynecol Oncol 64: 126–129

    PubMed  CAS  Google Scholar 

  • Creasman WT, Soper JT, McCarty KS Jr, McCarty KS Sr, Hinshaw W, Clarke-Pearson DL (1985) Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma. Am J Obstet Gynecol 151 (7): 922–932

    PubMed  CAS  Google Scholar 

  • Creasman WT, Henderson D, Hinshaw W,Clarke-Pearson DL (1986) Estrogen replacement therapy in the patient treated for endometrial cancer. Obstet Gynecol 67: 326–330

    CAS  Google Scholar 

  • Creasman WT, Morrow CR Bundy BN, Homesley HD, Graham JE, Heller PB (1987) Surgical pathologic spread patterns of endometrial cancer (a Gynecologic Oncology Group Study). Cancer 60: 2035–2041

    PubMed  CAS  Google Scholar 

  • Cummings SR, Eckert S, Krueger KA et al. (1999) The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. JAMA 281: 2189–2197

    PubMed  CAS  Google Scholar 

  • Demopoulos RI, Genega E,Vamvakas E, Karlson E, Mittal K (1982) Papillary carcinoma of the endometrium: morphometric predictors of survival. Int J Gynecol Pathol 15: 110–118

    Google Scholar 

  • Deppe G (1990) Chemotherapy for endometrial cancer. In: Deppe G (ed) Chemotherapy of gynecologic cancer, 2nd edn. Wiley-Liss, New York, pp 155–174

    Google Scholar 

  • du Bois A, Luck HJ, Meier W et al. (1997) Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase Ill trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group.Semin Oncol 24 [Suppl]: S15–44–15–52

    Google Scholar 

  • Dubeau I (1993) Etiology and detection of gynecologic cancer. In: Morrow CP,Curtin JP,Townsend DE (eds) Synopsis of gynecologic oncology,4th edn. Churchill Livingstone, New York, pp 1–22

    Google Scholar 

  • Elliott P, Green D, Coates A, Krieger M, Russell M, Coppleson M, Solomon J, Tattersall M (1994) The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer. Int J Gynecol Cancer 4: 84–93

    PubMed  Google Scholar 

  • Evans AT Ill, Gaffey TA, Malkasian GD Jr, Annegers JF (1980) Clinicopathologic review of 118 granulosa and 82 theca cell tumors.Obstet Gynecol 55: 231–238

    Google Scholar 

  • Fanning J,Tsukada Y, Piver MS (1990) Intraoperative frozen section diagnosis of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol Oncol 37: 47–50

    Google Scholar 

  • FIGO (1989) Announcement, FIGO stages - 1988 Revision. Gynecol Oncol 35: 125–126

    Google Scholar 

  • FIGO (1990) Changes in gynecologic cancer staging by the International Federation of Gynecology and Obstetrics. Am J Obstet Gynecol 162: 610–611

    Google Scholar 

  • Fisher B,Costantino JP,Wickerham DL et al.(1998)Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.J Nat! Cancer Inst 90:1371–1388

    Google Scholar 

  • Fishman DA, Roberts KB, Chambers JT, Kohorn El, Schwartz PE, Chambers SK (1996) Radiation therapy as exclusive treatment for medically inoperable patients with stage I and II endometrioid carcinoma of the endometrium. Gynecol Oncol 61: 189–196

    PubMed  CAS  Google Scholar 

  • Girardi F, Petru E, Heydarfadai M, Haas J, Winter R (1993) Pelvic lymphadenectomy in the surgical treatment of endometrial cancer.Gynecol Oncol 49: 177–180

    CAS  Google Scholar 

  • Goff BA, Goodman A, Muntz HG, Fuller AF, Nikrui N, Rice LW (1994) Surgical stage IV endometrial carcinoma:a study of 47 cases.Gynecol Oncol 52: 237–240

    CAS  Google Scholar 

  • Goff BA, Rice LW (1990) Assessment of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol Oncol 38: 46–48

    PubMed  CAS  Google Scholar 

  • Gretz HF, Economos K, Husain A et al. (1996) The practice of surgical staging and its impact on adjuvant treatment recommendations in patientswith stage I endometrial carcinoma.Gynecol Oncol 61: 409–415

    Google Scholar 

  • Hall JB,Young RH, Nelson JH (1984) The prognostic significance of adenomyosis in endometrial carcinoma. Gynecol Oncol 17: 32–40

    Google Scholar 

  • Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R (1982) Uterine papillary serous carcinoma:a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 6: 93–108

    PubMed  CAS  Google Scholar 

  • Homesley HD, Kadar N, Barrett RJ, Lentz SS (1992) Selective pelvic and peraortic lymphadenectomy does not increase morbidity in surgical staging of endometrial carcinoma. Am J Obstet Gynecol 167: 12251230

    Google Scholar 

  • Janicek MF, Rosenshein MB (1994) Invasive endometrial cancer in uteri resected for atypical endometrial hyperplasia.Gynecol Oncol 52:373378

    Google Scholar 

  • Jeyarajah AR, Gallagher CJ, Blake PR, Oram DH, Dowsett M, Fisher C, Oliver RTD (1996) Long-term follow-up of gonadotrophin-releasing hormone analogue treatment for recurrent endometrial cancer. Gynecol Oncol 63: 47–52

    PubMed  CAS  Google Scholar 

  • Judd HI,Shamonki IM,Frumar AM, Lagasse ID (1982) Origin of serum estro- diol in postmenopausal women. Obstet Gynecol 59: 680–686

    Google Scholar 

  • Kadar N, Homesley HD, Malfetano JH (1992) Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease. Gynecol Oncol 46: 145

    PubMed  CAS  Google Scholar 

  • Kadar N, Malfetano JH, Homesley HD (1993) Steroid receptor concentrations in endometrial carcinoma:effect on survival in surgically staged patients. Gynecol Oncol 50: 281–286

    PubMed  CAS  Google Scholar 

  • Kauppila A, Kujansuu E, Vihko R (1982) Cytosol estrogen and progestin receptors in endometrial carcinoma of patients treated with surgery, radiotherapy, and progestin, clinical correlates. Cancer 50: 2157–2162

    PubMed  CAS  Google Scholar 

  • Kikuchi A, Sultana J, Okai T, Kobayashi K, Taketani Y (1997) Intrauterine sonography for preoperative assessment of cervical invasion in endometrial carcinoma. Gynecol Oncol 65: 415–420

    PubMed  CAS  Google Scholar 

  • Kilgore LC, Partridge EE, Alvarez RD, Austin JM, Shingleton HM, Noojin F, Conner W (1995) Adenocarcinoma of the endometrium: Survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 56: 29–33

    PubMed  CAS  Google Scholar 

  • Kleine W, Fuchs A, deGregorio G, Geyer H (1982) Ostrogen- and Progesteronrezeptoren beim Korpuskarzinom and ihre klinische Bedeutung. Geburtsh Frauenhk 42: 884–887

    CAS  Google Scholar 

  • Kucera H, Vavra N (1991) Ein Risiko-Score für das operierte Endometriumkarzinom and seine Bedeutung für die adjuvante Strahlentherapie. Geburtsh Frauenhk 51: 798–805

    CAS  Google Scholar 

  • Kucera H (1996) Ergebnisse and Nebenwirkungen der Postoperativen Strahlentherapie beim Korpuskarzinom. In: Ladner HA (Hrsg) Gynäkologische Radiologie. Springer, Berlin Heidelberg New York Tokyo, pp 26–34

    Google Scholar 

  • Kurman RJ, Kaminski PF, Norris HJ (1985) The behavior of endometrial hyperplasia. A long-term study of„untreated” hyperplasia in 170 patients. Cancer 56: 403–412

    PubMed  CAS  Google Scholar 

  • Kurman RJ, Norris HJ (1987) Endometrial carcinoma. In: Kurman RJ (ed) Blaustein’s pathology of the female genital tract, 3rd edn. Springer, Berlin Heidelberg New York Tokyo, pp 338–372

    Google Scholar 

  • Kurman RJ, Norris Hi (1982) Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well differentiated carcinoma. Cancer 49: 2547

    PubMed  CAS  Google Scholar 

  • Ladner S (1997) Das Vaginalrezidiv beim Endometriumkarzinom. Ina ugural-Dissertation, Freiburg

    Google Scholar 

  • Larson DM, Johnson K, Olson KA (1992) Pelvic and paraaortic lymphadenectomy for surgical staging of endometrial cancer: Morbidity and mortality. Obstet Gynecol 79: 998–1001

    PubMed  CAS  Google Scholar 

  • Lee RB, Burke TW, Park RC (1990) Estrogen replacement therapy following treatment for stage I endometrial carcinoma. Gynecol Oncol 36: 189–191

    PubMed  CAS  Google Scholar 

  • Lellé RJ, Morley GW, Peters WA (1994) The role of vaginal hysterectomy in the treatment of endometrial carcinoma. Int J Gynecol Cancer 4: 342–347

    PubMed  Google Scholar 

  • Lesko SM, Rosenberg L, Kaufman DW, Stolley P, Warshauer ME, Lewis JL Jr, Shapiro S (1985) Cigarette smoking and the risk of endometrial cancer. N Engl J Med 313: 593–596

    PubMed  CAS  Google Scholar 

  • Levenback C, Burke TW, Silva E, Morris M, Gershenson DM, Kavanagh II, Wharton JT (1992) Uterine papillary serous carcinoma treated with cisplatin, doxorubicin, and cyclophosphamide. Gynecol Oncol 46: 317321

    Google Scholar 

  • Lo SST, Cheng KL, Ng TY,Wong LC, Ngan HYS (1996) The prognostic significance of positive peritoneal cytology in endometrial cancer. Int J Gynecol Cancer 6: 473–476

    Google Scholar 

  • Lutz MH, Underwood PB Jr, Kreutner A Jr, Miller MC (1978) Endometrial carcinoma:a new method of classification of therapeutic and prognostic significance. Gynecol Oncol 6: 83–94

    PubMed  CAS  Google Scholar 

  • Mack TM (1985) Estrogen replacement therapy in the etiology of endometrial Cancer.ln:Bolla M (ed) Endometrial cancers.5th Cancer Res.Workshop, Grenoble. Karger, Basel, pp 22–30

    Google Scholar 

  • Mangioni C, DePalo G,Marubini E, Del Vecchio M (1993) Surgical pathologic staging in apparent stage I endometrial carcinoma. Int J Gynecol Cancer 3: 373–384

    Google Scholar 

  • Mariani A, Sebo TJ, Katzmann JA, Keeney GL, Roche PC, LesnickTG, Podratz KC (2000) Pretreatment assessment of prognostic indicators in endometrial cancer. Am J Obstet Gynecol 182: 1535–1544

    CAS  Google Scholar 

  • Marziale P, Atlante G, Pozzi M, Diotallevi F, lacovelli A (1989) 426 cases of stage I endometrial carcinoma:a clinicopathological analysis.Gynecol Oncol 32: 278–281

    Google Scholar 

  • Meerpohl HG (1991) Systemic chemotherapy for advanced or recurrent endometrial cancer. In: Kleine W et al. (Hrsg) Therapie des Endometriumkarzinoms. Springer, Berlin Heidelberg New York Tokyo, pp 133141

    Google Scholar 

  • Milosevic ME, Dembo AJ,Thomas GM (1992)The clinical significance of malignant peritoneal cytology in stage I endometrial carcinoma. Int J Gynecol Cancer 2: 225–235

    Google Scholar 

  • Minckwitz G von, Kühn W, Kaufmann M, Feichter GE, Heep J, Schmid H, Bastert G (1994) Prognostic importance of DNA-ploidy and S-phase fraction in endometrial cancer. Int J Gynecol Cancer 4: 250–256

    Google Scholar 

  • Minckwitz G von, Loibl S, Brunnert K et al., for the South West German Gynecologic Oncology Group (SWGGOG) (2002) Adjuvant endocrine treatment with medroxyprogesterone acetate or tamoxifen in stage I and II endometrial cancer - a multicentre, open, controlled, prospectively randomised trial.Euri Cancer 38: 2266–2272

    Google Scholar 

  • Morris PC, Anderson JR, Anderson B, Buller RE (1995) Steroid hormone receptor content and lymph node status in endometrial cancer. Gynecol Oncol 56: 406–411

    PubMed  CAS  Google Scholar 

  • Morrow CP, Bunda BN, Homesley HD, Creasman WT, Hornback NB, Kurman R, Thigpen JT (1990) Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high risk endometrial carcinoma stage I and occult II:A Gynecologic Oncology Group study.Gynecol Oncol 36: 166–171

    CAS  Google Scholar 

  • Morrow CP, Bundy BN,Kurmann Ri,Creasman WT, Heller PB, Homesley HD, Graham JE (1991) Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium. A Gynecologic Oncology Group study. Gynecol Oncol 40: 55–65

    CAS  Google Scholar 

  • Moss WT, Brand WN, Battifora H (1979) Radiation oncology - rationale, technique, results, 5th edn. CV Mosby, St. Louis, p 492

    Google Scholar 

  • Nguyen C, Souhami L, Roman TN, Clark BG (1995) High-dose-rate brachytherapy as the primary treatment of medically inoperable stage I-II endometrial carcinoma. Gynecol Oncol 59: 370–375

    PubMed  CAS  Google Scholar 

  • Nyholm HO, Nielsen AL, Norup P (1993) Endometrial cancer in postmenopausal women with and without previous estrogen replacement treatment.Comparison of clinical and histopathological characteristics. Gynecol Oncol 49: 229–235

    PubMed  CAS  Google Scholar 

  • Persson I (1985) The risk of endometrial and breast cancer after estrogen treatment. A review of epidemiological studies. Acta Obstet Gynecol Scand Suppl 130: 59–66

    PubMed  CAS  Google Scholar 

  • Pettersson F (1994) Annual report on the results of treatment in gynecol- ogical cancer, vol 22. Editorial Office, Radiumhemmet, Stockholm

    Google Scholar 

  • Pfisterer J, Kommoss F, Sauerbrei W, Rendl I, Kiechle M, Kleine W, Pfleiderer A (1995) Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma. Gynecol Oncol 58: 149–156

    PubMed  CAS  Google Scholar 

  • Pfleiderer A (1991) Die Therapie des Endometriumkarzinoms. Geburtsh Frauenhk 51: 787–797

    CAS  Google Scholar 

  • Pfleiderer A (1996) Zur gynäkologischen Onkologie and operativen Gynäkologie im Alter.Gynäkologe 29: 770–774

    Google Scholar 

  • Pfleiderer A, Kleine W (1985) Risk factors of endometrial carcinoma. In: Bolla M (ed) Endometrial cancers.5th Cancer Res.Workshop,Grenoble 1985. Karger, Basel, pp 12–21

    Google Scholar 

  • Pierga JY, Dieras V, Paraiso D et al. (1996) Treatment of advanced or recurrent endometrial carcinoma with combination of etoposide, cisplatin and 5–fluorouracil:A phase II study. Gynecol Oncol 60: 59–63

    PubMed  CAS  Google Scholar 

  • Pike MC, Spicer DV (2000) Hormonal contraception and chemoprevention of female cancers. Endocr Relat Cancer 7: 73–83

    PubMed  CAS  Google Scholar 

  • Price FV, Chambers SK, Carcangiu ML, Kohorn EI, Schwartz PE, Chambers JT (1993) Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma. Gynecol Oncol 51: 383–389

    PubMed  CAS  Google Scholar 

  • Reddoch JM, Burke TW, Morris M,Tornos C, Levenback C, Gershenson DM (1995) Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme. Gynecol Oncol 59: 221–225

    CAS  Google Scholar 

  • Reich O, Winter R, Pickel H,Tamussino K, Haas J, Petru E (1996) Does the size of pelvic lymph nodes predict metastatic involvement in patients with endometrial cancer? Int J Gynecol Cancer 6: 445–447

    Google Scholar 

  • Robboy SJ, Bentley RC, Krigman H, Silverberg SG, Norris HJ, Zaino RJ (1994) Synoptic reports in gynecologic pathology. Int J Gynecol Pathol 13: 161–174

    PubMed  CAS  Google Scholar 

  • Rosenberg P, Blom R, Hogberg T, Simonsen E (1993) Death rate and recurrence pattern among 841 clinical stage I endometrial cancer patients with special reference to uterine papillary serous carcinoma.Gynecol Oncol 51: 311–315

    CAS  Google Scholar 

  • Seelbach-Göbel B, Rempen A, Kristen P (1995) Transvaginaler Ultraschall am Endometrium in der Postmenopause. Geburtsh Frauenhk 54: 59–64

    Google Scholar 

  • Shelley DR, Dunaif A (1990) Polycystic ovary syndrome. Compr Ther 16: 26–34

    PubMed  CAS  Google Scholar 

  • Shumsky AG, Brasher PMA, Stuart GCE, Nation JG (1997) Risk-specific follow-up for endometrial carcinoma patients. Gynecol Oncol 65: 379382

    Google Scholar 

  • Sood AK, Buller RE, Burger RA, Dawson JD, SoroskyJI, Berman M (1997) Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome. Obstet Gynecol 90: 441–447

    CAS  Google Scholar 

  • Sutton GP, Blessing JA, DeMars LR, Moore D, Burke TW,Grendys EC (1996) A phase 11 GOG trial of ifosfamid and mesna in advanced or recurrent adenocarcinoma of the endometrium. Gynecol Oncol 63: 25–27

    CAS  Google Scholar 

  • Tepper R, Beyth Y, Altaras MM, Zalel Y, Shapira J, Cordoba M, Cohen 1(1997) Value of sonohysterography in asymptomatic postmenopausal tamoxifen-treated patients. Gynecol Oncol 64: 386–391

    Google Scholar 

  • Thipgen JT, Blessing JA (1989) Progestin therapy for advanced or recurrent endometrial carcinoma: The GOG experience. Abst. Progestin action and progesteron receptors in breast cancer,April 6–7, Washington DC, NCI, AG

    Google Scholar 

  • Tsuda H, Kawabata M,Yamamoto K, Inoue T, Umesaki N (1997) Prospective study to compare endometrial cytology and transvaginal ultrasonography for identification of endometrial malignancies.Gynecol Oncol 65: 383–386

    CAS  Google Scholar 

  • Umpierre SA, BurkeTW,Tornos C, Ordonez N, Levenback C, Morris M (1994) Immunocytochemical analysis of uterine papillary carcinomas for estrogen and progesterone receptors. Int J Gynecol Pathol 13: 127130

    Google Scholar 

  • Vergote I, Kjörstad K, Abeler V, Kolstad P (1989) A randomized trial of adjuvant progestagen in early endometrial cancer. Cancer 64: 1011–1016

    PubMed  CAS  Google Scholar 

  • Vuento MH, Stenman UH, Pirhonen JP, Mäkinen JI, Laippala PJ, Salmi TA (1997) Significance of a single CA 125 assay combined with ultrasound in the early detection of ovarian and endometrial cancer. Gynecol Oncol 64: 141–146

    PubMed  CAS  Google Scholar 

  • Watson P, Lynch IIT (1993) Extracolonic cance in hereditary nonpolyposis colorectal cancer. Cancer 71: 677–685

    PubMed  CAS  Google Scholar 

  • Wilson TO, Podratz KC, Gaffey TA, Malkasian GD Jr, O’Brien PC, Naessens JM (1990) Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma. Am J Obstet Gynecol 162: 418–423

    Google Scholar 

  • Yokoyama Y, Maruyama H, Sato S, Saito Y (1997) Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers. Gynecol Oncol 64: 411–417

    PubMed  CAS  Google Scholar 

  • Zablow A, Adams M, Gregori C, Breen JL, Sanfilippo U (1994) Stage II adenocarcinoma of the endometrium treated by two standard regimens of combined preoperative irradiation and surgery. Int J Gynecol Cancer 4: 265–271

    PubMed  Google Scholar 

  • Zheng W,Cao P,Zheng M, Kramer EE,Godwin TA (1996) p53 overexpression and bc1–2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes. Gynecol Oncol 61: 167–174

    Google Scholar 

Download references

Authors
  1. G. von Minckwitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Pfleiderer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Kaufmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

von Minckwitz, G., Pfleiderer, A., Kaufmann, M. (2004). Endometriumkarzinom. In: Die Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-06670-6_45

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-06670-6_45

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-06671-3

  • Online ISBN: 978-3-662-06670-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation